Group SFA-before intervention. by Nan Tang (642590)

Subjects:

Lost cases. by Nan Tang (642590)

Subjects:

Group control-before intervention. by Nan Tang (642590)

Subjects:

Patient satisfaction with SFA intervention(%). by Nan Tang (642590)

Subjects:

Pre-Experiment. by Nan Tang (642590)

Subjects:

Group SFA-after intervention. by Nan Tang (642590)

Subjects:

Flowchart of literature screening process. by Shangtian Wang (20933822)

Subjects:

Basic characteristics of included literature. by Shangtian Wang (20933822)

Subjects:

Raw data. by Shangtian Wang (20933822)

Subjects:

Forest plot of overall analysis results. by Shangtian Wang (20933822)

Subjects:

Forest plot for subgroups of infection types. by Shangtian Wang (20933822)

Subjects:

Sensitivity analysis results. by Shangtian Wang (20933822)

Subjects:

Forest plot for subgroups of analysis types. by Shangtian Wang (20933822)

Subjects:

Forest plot for subgroups of study types. by Shangtian Wang (20933822)

Subjects:

Bar graphs showing the total loss rates and 95% confidence intervals for each region in Ethiopia, Kenya, and Benin. by Beatrice T. Nganso (4114768)

Subjects:

Analysis of SAS, SDS, PSQI, and FertiQoL scores. by Nan Tang (642590)

Subjects:

Map with color coding showing the relative risk of loss at the regional level for each country in Sub-Saharan Africa. by Beatrice T. Nganso (4114768)

Subjects:

Pie charts showing the different patterns of risk factors associated with total colony losses. by Beatrice T. Nganso (4114768)

Subjects:

Summary map of all contacts with statistically significant SVM classifications. by Alexander P. Rockhill (6053618)

“…Yellow indicates an increase in time-frequency clusters during number trials versus inter-trial intervals while blue indicates a decrease in time-frequency clusters. White regions in the plot indicate that no directional change occurred. …”

Effects of 1466 on capsid and pgRNA encapsidation compared to known CAM-A and CAM-E inhibitors. by Daniel P. Bradley (10306893)